FGF23 and cardiovascular disorder: Further, significant elevations in circulating phosphate and FGF‐23 in CKD have been shown to associate with increased morbidity and mortality, particularly from cardiovascular disease (Ix et al., 2012; Kestenbaum et al., 2005; London et al., 2007; Mirza et al., 2009).